PASSAMONTI, FRANCESCO

PASSAMONTI, FRANCESCO  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 127 (tempo di esecuzione: 0.006 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 23-giu-2017 F. PassamontiA. Rambaldi + Article (author) -
A final note about ibrutinib in relapsed or refractory CLL: Conclusive results from RESONATE sound definitely good! 1-gen-2019 Passamonti, Francesco + Article (author) -
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion 1-gen-2017 PASSAMONTI, FRANCESCO + Article (author) -
A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis 1-gen-2018 Passamonti, Francesco + Article (author) -
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 1-gen-2022 Guidetti, AnnaTurrini, MauroCorradini, PaoloPassamonti, Francesco + Article (author) -
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis 1-mar-2022 Finazzi, Maria ChiaraGuidetti, AnnaCattaneo, DanielePassamonti, Francesco + Article (author) -
A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence 1-gen-2017 F. Passamonti + Article (author) -
Analysis of three screening methods for the detection of calreticulin gene mutations 1-gen-2020 Passamonti F. + Article (author) -
Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib 1-gen-2022 Passamonti F. + Article (author) -
Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations 1-gen-2022 Passamonti, Francesco + Article (author) -
Associations between gender, disease features and symptom burden in the MPN population : An analysis by the MPN QOL International Working Group 1-gen-2017 F. PassamontiA. Rambaldi + Article (author) -
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts 1-mag-2018 Passamonti, FrancescoFinazzi, Maria ChiaraRambaldi, Alessandro + Article (author) -
Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project 1-gen-2021 Vener, ClaudiaPassamonti, Francesco + Article (author) -
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey 20-set-2022 Guidetti, AnnaPassamonti, FrancescoCorradini, Paolo + Article (author) -
Cell therapy in inflammartory bowel disease 1-gen-2021 Passamonti F. + Article (author) -
Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy 1-gen-2016 PASSAMONTI, FRANCESCO + Article (author) -
Chronic myeloproliferative neoplasms in the elderly 1-gen-2018 Passamonti, Francesco + Article (author) -
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 1-gen-2021 Passamonti F.Bolli N.Rambaldi A. + Article (author) -
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 1-ott-2020 Passamonti F.Merli F.Cairoli R.Galimberti S.Falini B.Derenzini E.Conconi A.Cuccaro A.Bocchia M.Marchesi F.Federici A. B.Venditti A.Oberti M.Corradini P. + Article (author) -
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years [Clinical relevance of clonal hematopoiesis in persons aged >= 80 years] 25-nov-2021 Asselta R.Duga S.Selmi C.Bicchieri M.Passamonti F.Bolli N. + Article (author) -